Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer

By Winter D.L.   Hanlon A.L.   Raysor S.L.   Watkins-Bruner D.   Pinover W.H.   Hanks G.E.   Tricoli J.V.  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 614-618

Elsevier

Access to resources Recommend Favorite

Chemosensitisation of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor

By Hellawell G.   Ferguson D.   Brewster S.   Macaulay V.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 36-36

Elsevier

Access to resources Recommend Favorite

IGF, PSA, glandular hyperplasia and cancer risk in the prostate

By Barrass B.J.R.   Persad R.A.   Gillatt D.A.   Neal D.E.   Hamdy F.C.   Oliver S.E.   Gunnell D.J.   Donovan J.L.   Peters T.J.   Holly J.M.P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Proliferative and mineralogenic effects of insulin, IGF-1, and vanadate in fish osteoblast-like cells

By Tiago Daniel  

Journal of Bone and Mineral Metabolism, Vol. 29, Iss. 3, 2011-05 ,pp. : 377-382

Springer Publishing Company

Access to resources Recommend Favorite

Fetal Therapy with rhIGF-1 in a Rabbit Model of Intrauterine Growth Retardation

By Skarsgard E.D.   Amii L.A.   Dimmitt R.A.   Sakamoto G.   Brindle M.E.   Moss R.L.  

Journal of Surgical Research, Vol. 99, Iss. 1, 2001-07 ,pp. : 142-146

Academic Press

Access to resources Recommend Favorite